Search research articles
Contact Us
Filters
Showing results (301-310 of 310) with videos related to
Page
of 31
Sort By:
You have reached the last page of results.
This site can display upto 310 results.
Leukemia
|
February 7, 2012
Preclinical activity of LBH589 alone or in combination with chemotherapy in a xenogeneic mouse model of human acute lymphoblastic leukemia
A Vilas-Zornoza, X Agirre, G Abizanda, et al.
Blood Cancer Journal
|
October 3, 2015
The expression level of BAALC-associated microRNA miR-3151 is an independent prognostic factor in younger patients with cytogenetic intermediate-risk acute myeloid leukemia
M Díaz-Beyá, S Brunet, J Nomdedéu, et al.
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia
|
August 30, 2007
[Recommendations for diagnosis and treatment of aged hypertensives]
J Macías, N R Robles, J Herrera, et al.
The Hematology Journal : the Official Journal of the European Haematology Association
|
March 29, 2002
Increased conventional chemotherapy does not improve survival in multiple myeloma: long-term results of two PETHEMA trials including 914 patients
J Bladé, J F San Miguel, M Fontanillas, et al.
British Journal of Haematology
|
July 27, 2001
Pretreatment characteristics and clinical outcome of acute promyelocytic leukaemia patients according to the PML-RAR alpha isoforms: a study of the PETHEMA group
M González, E Barragán, P Bolufer, et al.
Leukemia Research
|
April 11, 2022
Response to azacitidine in patients with chronic myelomonocytic leukemia according to overlap myelodysplastic/myeloproliferative neoplasms criteria
A Triguero, B Xicoy, L Zamora, et al.
Journal of Hematology & Oncology
|
July 26, 2018
Frequency and clinical impact of CDKN2A/ARF/CDKN2B gene deletions as assessed by in-depth genetic analyses in adult T cell acute lymphoblastic leukemia
E Genescà, A Lazarenkov, M Morgades, et al.
Leukemia
|
December 25, 2009
Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008
M Brüggemann, A Schrauder, T Raff, et al.
ESMO Open
|
March 10, 2022
Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus
C Buske, M Dreyling, A Alvarez-Larrán, et al.
Current Alzheimer Research
|
June 30, 2012
Progression of Alzheimer disease in Europe: data from the European ICTUS study
B Vellas, L Hausner, L Frölich, et al.
Page
of 31
Search research articles
Search
Showing results (301-310 of 310) with videos related to
Sort By:
Page
of 31
You have reached the last page of results.
This site can display upto 310 results.
Leukemia
|
February 7, 2012
Preclinical activity of LBH589 alone or in combination with chemotherapy in a xenogeneic mouse model of human acute lymphoblastic leukemia
A Vilas-Zornoza, X Agirre, G Abizanda, et al.
Blood Cancer Journal
|
October 3, 2015
The expression level of BAALC-associated microRNA miR-3151 is an independent prognostic factor in younger patients with cytogenetic intermediate-risk acute myeloid leukemia
M Díaz-Beyá, S Brunet, J Nomdedéu, et al.
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia
|
August 30, 2007
[Recommendations for diagnosis and treatment of aged hypertensives]
J Macías, N R Robles, J Herrera, et al.
The Hematology Journal : the Official Journal of the European Haematology Association
|
March 29, 2002
Increased conventional chemotherapy does not improve survival in multiple myeloma: long-term results of two PETHEMA trials including 914 patients
J Bladé, J F San Miguel, M Fontanillas, et al.
British Journal of Haematology
|
July 27, 2001
Pretreatment characteristics and clinical outcome of acute promyelocytic leukaemia patients according to the PML-RAR alpha isoforms: a study of the PETHEMA group
M González, E Barragán, P Bolufer, et al.
Leukemia Research
|
April 11, 2022
Response to azacitidine in patients with chronic myelomonocytic leukemia according to overlap myelodysplastic/myeloproliferative neoplasms criteria
A Triguero, B Xicoy, L Zamora, et al.
Journal of Hematology & Oncology
|
July 26, 2018
Frequency and clinical impact of CDKN2A/ARF/CDKN2B gene deletions as assessed by in-depth genetic analyses in adult T cell acute lymphoblastic leukemia
E Genescà, A Lazarenkov, M Morgades, et al.
Leukemia
|
December 25, 2009
Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008
M Brüggemann, A Schrauder, T Raff, et al.
ESMO Open
|
March 10, 2022
Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus
C Buske, M Dreyling, A Alvarez-Larrán, et al.
Current Alzheimer Research
|
June 30, 2012
Progression of Alzheimer disease in Europe: data from the European ICTUS study
B Vellas, L Hausner, L Frölich, et al.
Page
of 31